Hepatotoxicity and Childhood Leukemia
Author Information
Author(s): K. Schmiegelow, M. Pulczynska
Primary Institution: University Hospital, Copenhagen
Hypothesis
Does the degree of hepatotoxicity during maintenance chemotherapy affect the risk of relapse in children with acute lymphoblastic leukemia?
Conclusion
Higher levels of hepatotoxicity during chemotherapy are associated with a lower risk of relapse in children with acute lymphoblastic leukemia.
Supporting Evidence
- Patients with hepatotoxicity had a 4.5 year probability of complete remission of 0.70 compared to 0.50 for those without.
- Significant correlation found between mean AT levels and relapse risk.
- Boys had a higher relapse risk compared to girls (P = 0.003).
- Patients with mATMT > 40 IU I-1 had a lower risk of relapse than those with mATMT < 40 IU I-1.
Takeaway
Kids with leukemia who have liver problems during treatment might actually have a better chance of staying healthy than those who don't.
Methodology
The study analyzed the relationship between hepatotoxicity and relapse risk in children undergoing maintenance chemotherapy for leukemia, measuring liver enzyme levels and white blood cell counts.
Potential Biases
Potential bias due to variations in drug dosage and compliance among patients.
Limitations
The study excluded patients with major protocol violations and those without complete data.
Participant Demographics
115 children aged 1 to 15 years, including 67 boys and 48 girls.
Statistical Information
P-Value
P = 0.03 for haematological relapse risk; P = 0.06 for overall relapse risk.
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website